Determination of the Relative Toxicity of Amphotericin B Formulations: A Red Blood Cell Potassium Release Assay
- 1 January 1999
- journal article
- Published by Taylor & Francis in Drug Delivery
- Vol. 6 (2) , 81-88
- https://doi.org/10.1080/107175499266995
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- The Formation of Amphotericin B Ion Channels in Lipid BilayersBiochemistry, 1997
- Randomized Comparison of Amphotericin B Deoxycholate Dissolved in Dextrose or Intralipid for the Treatment of AIDS-Associated Cryptococcal MeningitisClinical Infectious Diseases, 1996
- Development, Characterization, Efficacy and Mode of Action of Ambisome, A Unilamellar Liposomal Formulation of Amphotericin BJournal of Liposome Research, 1993
- Liposomal and Lipid Formulations of Amphotericin BClinical Pharmacokinetics, 1992
- Structure-activity study of inhibition of amphotericin B (Fungizone) binding to sterols, toxicity to cells, and lethality to mice by esters of sucroseAntimicrobial Agents and Chemotherapy, 1991
- Amphotericin B: current understanding of mechanisms of actionAntimicrobial Agents and Chemotherapy, 1990
- Unusual lipid structures selectively reduce the toxicity of amphotericin B.Proceedings of the National Academy of Sciences, 1988
- Effects of the detergent sucrose monolaurate on binding of amphotericin B to sterols and its toxicity for cellsBiochemical and Biophysical Research Communications, 1988
- The Release of Potassium Ions from Candida albicans in the Presence of Polyene AntibioticsJournal of General Microbiology, 1974
- Increased Permeability of Human Erythrocytes Induced by Amphotericin BThe Journal of Infectious Diseases, 1971